Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT · NASDAQ Global Market
+$0.06 today
Vol 8.17M · Avg 3.15M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+27.38%
Period High
$5.30
Period Low
$2.45
Latest
$3.35
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
LB Pharmaceuticals Inc Common Stock
NASDAQ:LBRX
$847.81M
Design Therapeutics, Inc.
NASDAQ:DSGN
$756.04M
Solid Biosciences Inc.
NASDAQ:SLDB
$603.80M
Annexon, Inc.
NASDAQ:ANNX
$586.12M
Autolus Therapeutics plc
NASDAQ:AUTL
$409.86M
Aura Biosciences, Inc.
NASDAQ:AURA
$398.68M
DBV Technologies S.A.
NASDAQ:DBVT
$377.25M
I-Mab
IMAB
$235.66M
Quantum-Si incorporated
NASDAQ:QSI
$193.45M
Galectin Therapeutics Inc.
NASDAQ:GALT
$183.74M
What is the latest RCKT filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does RCKT have?
Intrinsic Alpha currently shows 20 recent filings for RCKT.
Explore More
Continue the stock analysis
Jump to another research area for this company.